Evidence map›Paper›PMID 34932117›Full record

ArticleTranslational vision science & technology2021

AxonDeep: Automated Optic Nerve Axon Segmentation in Mice With Deep Learning.

Wenxiang Deng, Adam Hedberg-Buenz, Dana A Soukup, Sima Taghizadeh, Kai Wang, Michael G Anderson, Mona K Garvin

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wenxiang DengDepartment of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA, USA.
Adam Hedberg-BuenzIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Dana A SoukupIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Sima TaghizadehDepartment of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA, USA.
Kai WangDepartment of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Michael G AndersonIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Mona K GarvinDepartment of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA, USA.
University of Iowa · USIowa City VA Health Care System · US

Funding

Stem Cell and Organoid CoreP30EY025580 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins · 2016 to 2026
$6.9M
Diabetes Research Training Program Diversity SupplementT32DK112751 · NIDDK · UNIVERSITY OF IOWA · PI Andrew W Norris · 2017 to 2026
$4.8M
CRISPR/Cas9 approaches to model exfoliation syndromeR21EY029991 · NEI · UNIVERSITY OF IOWA · PI ANDERSON, MICHAEL G, FINGERT, JOHN H · 2019 to 2020
$424k
Therapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma ProgressionI01RX001481 · VA · IOWA CITY VA MEDICAL CENTER · PI ANDERSON, MICHAEL G · 2015 to 2019
–
Center for the Prevention and Treatment of Visual LossI50RX003002 · VA · IOWA CITY VA MEDICAL CENTER · PI RANDY H. KARDON, MARKUS H. KUEHN · 2019 to 2026
–
NEI NIH HHS P30 EY025580NEI NIH HHS R21 EY029991NIDDK NIH HHS T32 DK112751RRD VA I01 RX001481RRD VA I50 RX003002
6 · The paper itself

Abstract

Purpose: Optic nerve damage is the principal feature of glaucoma and contributes to vision loss in many diseases. In animal models, nerve health has traditionally been assessed by human experts that grade damage qualitatively or manually quantify axons from sampling limited areas from histologic cross sections of nerve. Both approaches are prone to variability and are time consuming. First-generation automated approaches have begun to emerge, but all have significant shortcomings. Here, we seek improvements through use of deep-learning approaches for segmenting and quantifying axons from cross-sections of mouse optic nerve. Methods: Two deep-learning approaches were developed and evaluated: (1) a traditional supervised approach using a fully convolutional network trained with only labeled data and (2) a semisupervised approach trained with both labeled and unlabeled data using a generative-adversarial-network framework. Results: From comparisons with an independent test set of images with manually marked axon centers and boundaries, both deep-learning approaches outperformed an existing baseline automated approach and similarly to two independent experts. Performance of the semisupervised approach was superior and implemented into AxonDeep. Conclusions: AxonDeep performs automated quantification and segmentation of axons from healthy-appearing nerves and those with mild to moderate degrees of damage, similar to that of experts without the variability and constraints associated with manual performance. Translational Relevance: Use of deep learning for axon quantification provides rapid, objective, and higher throughput analysis of optic nerve that would otherwise not be possible.

Indexed as

Deep LearningGlaucomaOptic Nerve InjuriesAnimalsAxonsMiceOptic Nerve

Identifiers

PMID34932117
PMCPMC8709929
OpenAlexW4225736910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.